Results 1 to 10 of about 37,839 (161)
Reliability of functional outcome measures in adults with neurofibromatosis 2 [PDF]
SAGE Open Medicine, 2022 Objective: To determine inter- and intra-rater reliability of functional performance outcome measures in people with neurofibromatosis 2. To ascertain how closely objective and subjective measures align. Methods: Twenty-nine people with neurofibromatosis
Rebecca Louise Mullin +4 more
doaj +2 more sources
Diffuse Meningiomatosis without Neurofibromatosis: A Rare Diagnosis with Atypical Presentation
Indian Journal of Radiology and Imaging, 2021 Meningiomas are amongst the most common neoplasms of the central nervous system; however, “multiple meningiomas” or “meningiomatosis” account for
Smily Sharma, Pankaj Sharma, Amit Kumar
doaj +1 more source
Case report of selumetinib as a novel therapy in a neurofibromatosis type 2-associated ependymoma
Molecular Therapy: Methods & Clinical Development, 2023 We report partial response (PR) to novel therapy with selumetinib in a patient with neurofibromatosis type 2 (NF2). A 25-year-old male presented with bilateral vestibular schwannomas, spinal cord intramedullary ependymomas, cranial and spinal meningiomas,
Nigel Blackwood +2 more
doaj +1 more source
Third nerve palsy as a presenting feature of neurofibromatosis 2 – A case report
TNOA Journal of Ophthalmic Science and Research, 2023 Neurofibromatosis 2 is an inheritable disorder characterized by bilateral vestibular nerve schwannomas. The usual presentation of such patients is hearing loss and difficulties with balancing.
Hennaav K Dhillon +2 more
doaj +1 more source
Recent advance on the treatment of neurofibromatosis type 2 ⁃ associated vestibular schwannoma
Chinese Journal of Contemporary Neurology and Neurosurgery, 2022 Neurofibromatosis type 2 (NF2) is an autosomal dominant inherited diseases. NF2 patients suffer a high mortality and disability rate. Bilateral vestibular schwannoma play an important role in its diagnosis and treatment. The balance of treatment and life
YANG Zhi⁃jun, LIU Pi⁃nan
doaj +1 more source
Medical Journal of Dr. D.Y. Patil Vidyapeeth, 2020 Neurofibromatosis type 2 (NF-2) is a rare autosomal dominant disorder characterized by multiple neoplasms which include meningiomas, schwannomas, and ependymomas. The most common tumors associated with NF-2 are bilateral vestibular schwannomas. We report
Amit Kharat +3 more
doaj +1 more source
Medical Journal of Dr. D.Y. Patil University, 2015 Neurofibromatosis 2 is a rare autosomal dominant neurocutaneous disorder classically characterized by bilateral acoustic schwannomas. Multiple other central, as well as peripheral central nervous system neoplasms as meningiomas and ependymomas, are also ...
Abhijit M Patil +3 more
doaj +1 more source
The Molecular Pathogenesis, Diagnostic Criteria, Symptoms, Clinical Manifestations, and Gene-Based Therapeutic Approaches in Neurofibromatosis [PDF]
مجله دانشگاه علوم پزشکی گرگان, 2023 Neurofibromatosis (NF) is a heterogeneous group of tumor predisposition syndromes that lead to malignancy in the central and peripheral nervous systems.
Fatemeh Shahraki, Morteza Oladnabi
doaj
Neurofibromatose 2: opções de restauração auditiva Neurofibromatosis 2: hearing restoration options
Brazilian Journal of Otorhinolaryngology, 2012 Neurofibromatose 2 (NF2) é uma doença autossômica dominante que, invariavelmente, cursa com surdez. Restauração auditiva pode ser realizada por meio do implante coclear (IC) ou implante auditivo de tronco encefálico (ABI).
Tatiana Alves Monteiro +5 more
doaj +1 more source
International Archives of Otorhinolaryngology, 2013 Summary Introduction: Few cases of cochlear implantation (CI) in neurofibromatosis type 2 (NF2) patients had been reported in the literature. The approaches described were translabyrinthine, retrosigmoid or middle cranial fossa.
Ricardo Ferreira Bento +4 more
doaj +1 more source